There are more than 100 million people living with obesity and over 35 million with type 2 diabetes and, for some, list price has been a real barrier to access and affordability," Jamey Millar, Executive Vice President, US Operations of Novo Nordisk Inc., says in a statement emailed to PEOPLE
Expanding awareness of their benefits could help more people access these treatments
One of the innovative options we offer is tirzepatide weight loss injections, designed to support adults who are struggling with obesity or excess weight alongside related health conditions
doi: 10.3390/biomedicines10061242 143 CasellasFBorruelNTorrejonAVarelaEAntolinMGuarnerFet al
Costcos Semaglutide Launch: Is It Really the Best Deal for Weight Loss
Supplier Selection Criteria Safe and tested API raw powder is what you should expect from an honest supplier